PharmaResources (Shanghai) Co., Ltd. (SHE:301230)

China flag China · Delayed Price · Currency is CNY
41.00
+1.20 (3.02%)
Mar 6, 2026, 4:00 PM EST
14.08%
Market Cap 5.62B
Revenue (ttm) 667.47M
Net Income (ttm) 36.59M
Shares Out 137.54M
EPS (ttm) 0.26
PE Ratio 159.70
Forward PE n/a
Dividend 0.50 (1.22%)
Ex-Dividend Date Jan 13, 2026
Volume 5,705,580
Average Volume 6,813,316
Open 39.48
Previous Close 39.80
Day's Range 39.48 - 41.41
52-Week Range 22.21 - 67.97
Beta 1.45
RSI 42.99
Earnings Date Apr 29, 2026

About SHE:301230

PharmaResources (Shanghai) Co., Ltd. engages in new drug research, development, and commercial production in China. It offers small molecule drug CRO, CDMO, and CMO. The company also involved in drug discovery, research, and development of pharmaceutical processes; and customized and commercial production of APIs, and key intermediates. It serves global pharmaceutical and biotechnology companies. PharmaResources (Shanghai) Co., Ltd. was founded in 2007 and is based in Shanghai, China [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 1,085
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301230
Full Company Profile

Financial Performance

In 2024, SHE:301230's revenue was 544.47 million, an increase of 11.18% compared to the previous year's 489.72 million. Earnings were 17.08 million, a decrease of -54.59%.

Financial Statements

News

There is no news available yet.